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Summary
 
Using a single vector targeting strategy, we have generated mice with a combined deficiency of
interleukin (IL)-4 and IL-13 to clarify their roles in T helper type 2 (Th2) cell responses. Using
immunological challenges normally characterized by a Th2-like response, we have compared
the responses of the double-deficient mice with those generated by wild-type, IL-4–deficient,
and IL-13–deficient mice. Using a pulmonary granuloma model, induced with 
 
Schistosoma
 
mansoni
 
 eggs, we demonstrate that although eosinophil infiltration, immunoglobulin E, and IL-5
production are reduced in the IL-4–deficient mice and IL-13–deficient mice, they are abol-
ished only in the combined absence of both cytokines. Furthermore, IL-4/13–deficient animals
are severely impaired in their ability to expel the gastrointestinal nematode 
 
Nippostrongylus bra-
siliensis
 
. Unexpectedly, 
 
N
 
.
 
 brasiliensis
 
–infected IL-4/13–deficient mice developed elevated IL-5
and eosinophilia, indicating that compensatory mechanisms exist for the expression of IL-5, al-
though serum IgE remained undetectable. IL-4/13–deficient mice default to a Th1-like phe-
notype characterized by the expression of interferon 
 
g
 
 and the production of IgG2a and IgG2b.
We conclude that IL-4 and IL-13 cooperate to initiate rapid Th2 cell–driven responses, and
that although their functions overlap, they perform additive roles.
Key words: interleukin 4 • interleukin 13 • T helper type 2 cells • immunoglobulin E • 
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A
 
lthough IL-4 is a key cytokine in the development of
Th2 cell responses (1, 2), recent studies of IL-4R–medi-
ated signaling pathways have implied the presence of alter-
 
native routes for Th2 cell induction (3–6). Indeed, we have
recently identified that the closely related cytokine, IL-13, can
also effect Th2 development (7), raising the question of how
these two cytokines may compensate for one another dur-
ing immune responses.
Both IL-4 and IL-13 are produced primarily by Th2-like
cells (8–10) and mast cells (11), and in vitro assay systems
have demonstrated that they share several biological func-
tions. These include inducing human B cells to undergo Ig
isotype switching to IgE (12) and regulating inflammatory
responses by suppressing TNF-
 
a
 
 and IL-1 expression from
monocytes and macrophages (12–14). However, there are
also specific functional differences between these mole-
cules, most notable of which is the ability of IL-4 to induce
T cell proliferation (15). Recent in vivo studies examining
the clearance of the parasitic gastrointestinal nematode 
 
Nip-
postrongylus brasiliensis 
 
from the intestines of infected cyto-
kine-deficient mice have also demonstrated divergent re-
sponses to IL-4 and IL-13. Although IL-4–deficient mice
 
expelled 
 
N
 
.
 
 brasiliensis
 
 worms with similar kinetics to wild-
type mice, IL-13–deficient animals or mice treated with an
inhibitor of IL-13 did not expel worms as efficiently (16, 17).
Analysis of IL-4 and IL-13 receptor usage has explained
certain aspects of the related responses. It is evident that
both IL-4 and IL-13 can cross-compete for IL-4R
 
a
 
, but
that only IL-4 binds directly to this receptor chain (18). IL-13
binds to its own primary binding chain (IL-13R
 
a
 
1), to
which IL-4 does not bind, and recruits IL-4R
 
a
 
 into a re-
ceptor complex resulting in an increase in binding affinity
and the initiation of signal transduction (19, 20). Further
differential signaling pathways can be envisaged for the
 
IL-4R, since IL-4 binding may recruit IL-13R
 
a
 
1 or IL-2R
 
g
 
c
into its active receptor complex (21, 22). This complexity
of receptor usage and the potential diversity of signaling
pathways combine with the temporal and spatial expression 
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of the individual ligands to create a diversity of possible
responses.
The genes encoding IL-4 and IL-13 are closely linked on
human chromosome 5 and the syntenic region of mouse
chromosome 11, and map to a cytokine gene cluster that
also includes IL-5, IL-3, and GM-CSF (23, 24). To study
the individual and combined contributions of IL-4 and IL-13
to immune responses, it would be advantageous to study
mouse lines in which the expression of both cytokines had
been disrupted; however, the close linkage of their genes
precludes the generation of such lines by simple interbreed-
ing of IL-4–deficient and IL-13–deficient mice. To circum-
vent these difficulties, we have used a single vector gene
targeting strategy to simultaneously disrupt both the IL-4
and IL-13 genes, thereby allowing us to investigate the po-
tential compensatory roles of these cytokines during Th2-
dominated immune responses in vivo. Using a Th2-driven
lung granuloma model, we demonstrate that IL-4 and IL-13
can partially compensate for each other and that granuloma
formation is abolished only in the absence of both cyto-
kines. Furthermore, we show that although IL-13 is primar-
ily involved in the expulsion of 
 
N
 
.
 
 brasiliensis
 
, the concomi-
tant disruption of IL-4 further impairs parasite clearance.
Interestingly, IL-4/13–deficient mice have demonstrated
the existence of compensatory mechanisms that still enable
the expression of IL-5 and subsequent eosinophilia after
 
N
 
.
 
 brasiliensis
 
 infection. We conclude that IL-4 and IL-13
act in concert to initiate rapid Th2-like responses, and that
their combined disruption can either abolish such responses
or significantly delay their onset, resulting in an inappropriate
Th1 response.
 
Materials and Methods
 
Targeted Disruption of the Mouse IL-13 and IL-4 Genes in Embry-
onic Stem Cells.
 
The single targeting vector consisted of 6 kb of
the IL-13 gene providing the 5
 
9
 
 arm of homology and 4.0 kb of
the IL-4 gene comprising the 3
 
9
 
 homology. The replacement
vector was constructed to insert the neomycin resistance gene
into an engineered SalI site in exon 3 of the IL-13 gene. Stop
codons in all three frames were inserted 5
 
9
 
 of the selectable
marker. The IL-4 region was a HindIII fragment containing exon
4. The targeting vector was linearized and electroporated into
E14.1 embryonic stem (ES)
 
1
 
 cells (7). Of 500 G418-resistant
clones screened by Southern blot analysis, using a probe made
with PCR primers (TGACCACAGGCAGTTTCACCTGC and
TTATCATCTCAGCCTCATATACAG), one was found to be
correctly targeted. Hybridization with a probe to the neomycin
sequence and IL-13 cDNA sequences confirmed the predicted
size of the targeted fragment and that only a single integration
had occurred. The targeted ES cell clone was microinjected into
3.5-d C57BL/6 blastocysts to generate chimeras. These mice
were mated with C57BL/6 mice and transmitted the ES cell geno-
type through the germline. Mice homozygous for the disrupted
IL-4 and IL-13 genes were obtained by interbreeding the het-
erozygotes. The IL-4/13 gene–targeted, IL-13 gene–targeted (7),
 
and wild-type animals used in the experiments reported below
were maintained on a 129 
 
3
 
 C57BL/6 (F
 
2
 
) background in a spe-
cific pathogen–free environment. IL-4
 
2
 
/
 
2
 
 mice (1) had been
backcrossed 10 times onto C57BL/6. Wild-type C57BL/6 mice
were included as controls in the schistosome egg experiments and
 
N
 
.
 
 brasiliensis
 
 experiments, and showed similar phenotypes to the
wild-type 129 
 
3
 
 C57BL/6 (F
 
2
 
) controls. Therefore, for the sake
of clarity only the wild-type 129 
 
3
 
 C57BL/6 (F
 
2
 
) controls are
presented.
 
Preparation of CD4
 
1
 
 T Cells.
 
Splenocytes were cultured on
plastic tissue culture plates for 1 h at 37
 
8
 
C to remove macrophages.
Nonadherent cells were incubated with biotinylated anti–I-A
 
b
 
antibody (clone AF6-120.1; Becton Dickinson), biotinylated
anti-CD8 antibody (clone 53-6.7; Becton Dickinson) and biotin-
ylated anti-B220 antibody (clone RA3-6B2; Becton Dickinson),
and streptavidin magnetic beads (MACS
 
®
 
; Miltenyi Biotec) fol-
lowed by magnetic field separation to remove MHC class II,
CD8, and B220-expressing cells. Cell purity was determined us-
ing FITC-labeled anti-CD4 and PE-labeled anti-CD8 antibodies
and was generally 90–95% CD4
 
1
 
 cells. Purified cells were cul-
tured on anti-CD3
 
e
 
 antibody–coated plates (10 
 
m
 
g/ml
 
 
 
of clone
2C11; Becton Dickinson) plus anti-CD28 antibody (1 
 
m
 
g/ml
 
 
 
of
clone 37.51; Becton Dickinson) in the presence of exogenous cy-
tokines or anticytokine antibody as indicated. IL-2 (10 ng/ml;
R&D Systems) was added to all cultures. Th2 cell differentiation
was promoted in the presence of 100 ng/ml IL-4 (R&D Systems)
and anti–IFN-
 
g
 
 antibody (10 
 
m
 
g/ml
 
 
 
of clone XMG1.2; Becton
Dickinson). Cells were cultured for 5 d, washed, and resuspended
at 10
 
6
 
 cells/ml for 24 h in the presence of anti-CD3. Supernatants
were analyzed by cytokine ELISA performed as above.
 
Granuloma Formation.
 
Synchronous pulmonary granulomas
were induced by intravenous injection of mice with 
 
Schistosoma
mansoni
 
 eggs. 
 
S
 
.
 
 mansoni
 
 eggs were isolated from the livers of in-
fected mice as described (25). Mice were sensitized to schisto-
some eggs by intraperitoneal injection of 5,000 live eggs. 2 wk
later, sensitized and naive mice, six mice per group, were injected
intravenously with 5,000 eggs to induce synchronous pulmonary
granulomas. 15 d after intravenous egg injection, mice were killed,
serum was recovered, and the draining mediastinal lymph nodes
were removed. The lungs were inflated with formol saline and
processed for histology. The size (diameter on hematoxylin and
eosin [H&E]-stained sections) and cell composition (percentage
of eosinophils on Giemsa-stained sections) of the granuloma sur-
rounding individual eggs were measured with an ocular microm-
eter using a double blind protocol by an investigator not involved
in the study; 
 
.
 
100 individual granulomas were analyzed per
group. Cells were prepared from pooled mediastinal lymph nodes
from each group and processed for cell culture as described (25).
3 
 
3
 
 10
 
6
 
 cells/ml were cultured and restimulated with 10 
 
m
 
g/ml
of soluble egg antigen. IL-4, IL-5, IL-10, and IFN-
 
g
 
 were assayed
using ELISA. Egg antigen–specific IgE, IgG1, and IgG2a isotype
responses were measured using ELISA as described (26). Statisti-
cal analysis was performed using analysis of variance (ANOVA)
and Dunnett’s test;
 
 P 
 
, 
 
0.05 was considered significant.
 
N. brasiliensis Infection.
 
Individual mice were inoculated sub-
cutaneously with 400 viable third-stage 
 
N
 
.
 
 brasiliensis
 
 larvae.
 
OVA Immunization.
 
8–10-wk-old mice were immunized in-
traperitoneally with 100 
 
m
 
g of OVA adsorbed to aluminium hy-
droxide (OVA/alum) with subsequent boost injections with 100 
 
m
 
g
of OVA/alum after 10 and 20 d. Serum samples were assayed for
Ig isotypes.
 
ELISA Assays.
 
Serum Igs were assayed using sandwich ELISA.
96-well plates were coated with anti-Ig isotype capture mAbs,
 
1
 
Abbreviations used in this paper: 
 
ES, embryonic stem; H&E, hematoxylin and
eosin; p.i., post-infection; Stat, signal transducer and activator of transcription. 
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and bound Ig of diluted serum samples was detected using biotin-
ylated anti-Ig isotype detection mAbs (Becton Dickinson). Con-
centrations were calculated using purified Ig isotypes as standards
(Becton Dickinson). OVA-specific ELISAs were performed by
coating 96-well plates with OVA at 2.5 
 
m
 
g/ml; bound Ig of di-
luted serum samples was detected using biotinylated anti-Ig iso-
type detection mAbs (Becton Dickinson). Cytokine ELISA also
used the sandwich format, with capture and detection antibodies
purchased from Becton Dickinson. ELISAs were performed ac-
cording to Becton Dickinson’s ELISA protocol. The IL-13 ELISA
was purchased from R&D Systems.
 
Results
 
Generation of Mice Double-deficient for IL-4 and IL-13.
 
Since the IL-4 and IL-13 genes are closely linked on mouse
chromosome 11 (
 
z
 
11 kb apart), it would be impractical to
attempt to mate IL-13–deficient mice with IL-4–deficient
mice in order to generate a crossover event between these
two genes. Therefore, we have used a single targeting con-
struct to exploit their juxtaposition and simultaneously tar-
get both genes. The mouse IL-4 and IL-13 genes are tran-
scribed in the same orientation, with the IL-13 gene lying
upstream of the IL-4 gene (A.N.J. McKenzie, unpublished
data). The targeting vector comprised a 5
 
9
 
 arm of homol-
ogy derived from the IL-13 gene, and a 3
 
9
 
 arm of homol-
ogy derived from the IL-4 gene positioned on either side of
the neomycin resistance cassette (Fig. 1 A). The resulting
homologous recombination event excises 
 
z
 
15 kb of in-
tervening sequence. Genotyping of wild-type (IL-4
 
1
 
/
 
1
 
IL-13
 
1
 
/
 
1
 
), heterozygous (IL-4
 
1
 
/
 
2
 
IL-13
 
1
 
/
 
2
 
), and homozy-
gous null (IL-4
 
2
 
/
 
2
 
IL-13
 
2
 
/
 
2
 
) mice is shown in Fig. 1 B. The
IL-4
 
2
 
/
 
2
 
IL-13
 
2
 
/
 
2
 
 mice were healthy and displayed no overt
phenotypic abnormalities. Analysis of the IL-4
 
2
 
/
 
2
 
IL-13
 
2
 
/
 
2
 
mice failed to detect IL-4 or IL-13 RNA transcripts from
activated lymphocytes using reverse transcriptase PCR as-
says (data not shown), and ELISAs also failed to identify
IL-4 or IL-13 protein in supernatants from spleen-derived
CD4
 
1
 
 T cells cultured under Th2 cell differentiation con-
ditions (Fig. 1 C). To determine the relative in vivo roles
of IL-4 and IL-13, we have assessed the immune responses
of the IL-4
 
2
 
/
 
2
 
IL-13
 
2
 
/
 
2
 
 animals, in combination with IL-
4–deficient mice (IL-4
 
2
 
/
 
2
 
) and IL-13–deficient mice (IL-
13
 
2
 
/
 
2
 
), to a range of immunological challenges that nor-
mally provoke a Th2 phenotype.
 
Induction of Synchronous Pulmonary Granuloma Formation
Using S. mansoni Eggs Is Abolished Only in the Combined Ab-
sence of IL-4 and IL-13.
 
To determine the relative in vivo
contribution of IL-4 and IL-13 in a Th2 cytokine–medi-
ated inflammatory response, we used a model system in
which synchronous pulmonary granuloma formation is in-
duced around 
 
S
 
.
 
 mansoni
 
 eggs (27). In this model, a cellular
granulomatous response develops around parasite eggs that
lodge in the lungs after their intravenous injection into mice.
This inflammatory response is characterized by the high-
level expression of Th2 cytokines (28).
We observed a profound inability of IL-4
 
2
 
/
 
2IL-132/2
mice to develop the Th2 cell–mediated inflammatory re-
sponse normally generated during synchronous pulmonary
granuloma formation in response to schistosome egg im-
munization (Fig. 2 A). This was in marked contrast to the
response generated by wild-type mice in which large eo-
sinophil-rich granulomas formed around eggs lodged in the
lung alveoli (Fig. 2, A and B). Furthermore, this wild-type
response was associated with expression of IL-4, IL-5, IL-10,
and IL-13 by cells recovered from the draining mediastinal
lymph nodes of the lung (Fig. 3 A) and the generation of
increased titers of egg antigen–specific IgE and IgG1 (Fig. 3
B). By contrast, the IL-42/2IL-132/2 mice did not develop
granulomas (Fig. 2 A), and eosinophil infiltration was virtu-
ally absent, although some monocyte infiltration was evident
(Fig. 2 B). Correlating with this, schistosome egg–chal-
lenged IL-4/13–deficient mice also expressed very low lev-
els of IL-5 (Fig. 3 A), the primary cytokine in the induc-
tion of eosinophil differentiation (29). IL-10 production
was also impaired, but there was a significant increase in the
expression of IFN-g (Fig. 3 A). Antigen-specific IgE was
also not detected in the serum of IL-42/2IL-132/2 mice,
and antigen-specific IgG1 was virtually absent (Fig. 3 B).
We also assessed how IL-4–deficient mice and IL-13–
deficient mice responded to schistosome egg challenge.
Figure 1. Simultaneous inactivation of the IL-4 and IL-13 genes by
homologous recombination. (A) The structure of the two loci, the single
targeting vector, and the predicted homologous recombination event are
shown. Targeted disruption results in the deletion of the 15-kb region ex-
tending from within exon 3 of the IL-13 locus (white boxes) to a HindIII
site in intron 3 of the IL-4 locus (gray boxes). H, HindIII; neo, neomycin
resistance cassette; tk, thymidine kinase cassette. (B) Southern blotting of
F2 tail genomic DNA. The indicated probe detects a 5.5-kb BglII frag-
ment in the wild-type IL-4 gene and a 7.5-kb fragment as a result of the
correct homologous recombination event between the IL-4 and IL-13 loci.
(C) Analysis of IL-4 and IL-13 expression by CD41 T cells. CD41 T
cells purified from two pooled spleens from two wild-type or two IL-42/2
IL-132/2 mice were stimulated under conditions promoting the expres-
sion of Th2 cytokines. Supernatants were analyzed by ELISA. Data are
representative of three repeat experiments. ND, not detected.1568 Simultaneous Disruption of IL-4 and IL-13 Genes
Although granuloma size and eosinophil infiltration were im-
paired in both single cytokine–deficient IL-42/2 and IL-132/2
mice, compared with wild-type (P , 0.001; Fig. 2, A–C),
they continued to develop a Th2 response with the expres-
sion of IL-5 and the infiltration of eosinophils (Fig. 2 C and
Fig. 3 A). Significantly, the granuloma response observed in
both of the single cytokine gene–disruption mouse lines was
substantially greater than that formed in the doubly targeted
mice (Fig. 2, A and B). It is also noteworthy that both the IL-
42/2 and IL-132/2 mice continued to produce egg antigen–
specific IgE and IgG1, although the levels of these Ig isotypes
were reduced relative to wild-type mice (Fig. 3 B).
Thus, the pulmonary granulomatous model demon-
strates that mice deficient in either IL-4 or IL-13 are still
capable of mounting a Th2-like response, albeit reduced
compared with wild-type mice, but that simultaneous dis-
ruption of IL-4 and IL-13 results in abrogation of the gran-
ulomatous response. This demonstrates that IL-4 and IL-13
perform compensatory roles that are essential in combina-
tion for the successful development of a Th2 cell–driven
inflammatory response, and that in their absence the re-
sponse becomes dominated by the Th1 cell cytokine IFN-g
(Fig. 3 A).
Expulsion of the Gastrointestinal Parasitic Nematode N. brasil-
iensis Is Further Impaired in the Combined Absence of IL-4 and
IL-13. Immunological responses to gastrointestinal para-
sitic worm infections are also characterized by the expres-
sion of Th2 cytokines (30). Using N. brasiliensis as a model,
recent studies have shown that although IL-4–deficient
mice expel these worms almost as efficiently as wild-type
animals (16, 17), IL-13–deficient mice display impaired ex-
pulsion kinetics (16). We have infected the IL-42/2 IL-132/2
mice with N. brasiliensis and compared the kinetics of worm
expulsion with that of wild-type and IL-132/2 animals
(Fig. 4). As expected, the wild-type mice expelled their
worms rapidly, with complete expulsion by day 10 post-
infection (p.i.), whereas the expulsion of worms from the
IL-132/2 mice was delayed beyond 10 d (Fig. 4). Signifi-
cantly, the combined ablation of both cytokines further de-
layed the expulsion of N. brasiliensis, with substantially
more worms present at day 14 p.i., even when compared
with IL-132/2 animals (Fig. 4). Thus, although IL-13 is ap-
parently the primary cytokine regulating N. brasiliensis ex-
pulsion, IL-4 does play an additional role in this process.
Interestingly, we have also found that treatment of IL-132/2
Figure 2. Analysis of pulmonary inflammatory response. (A) Morpho-
logical analysis of granuloma formation in wild-type, IL-42/2, IL-132/2,
and IL-42/2IL-132/2 mice. Cohorts of six mice were sensitized to S.
mansoni eggs by intraperitoneal injection of 5,000 live eggs. After 15 d,
these mice were injected intravenously with 5,000 eggs to induce syn-
chronous pulmonary granuloma. Mice were killed 15 d later. Lung sec-
tions were stained with H&E. Original magnification: 3100. (B) Deter-
mination of granuloma diameters in immunized mice. Lung sections were
stained with H&E, and at least 100 individual granulomas were measured
per group. Dashed line indicates the mean diameter of an egg. (C) Eo-
sinophil counts. After granuloma formation, the percent composition of
eosinophils in the granulomas was determined from Giemsa-stained lung
sections. Representative data from two repeat experiments (six to eight
mice per group). Data are presented as means 6 SD.
Figure 3. Cytokine and Ig responses to pulmonary challenge. (A) Cy-
tokine responses from activated lymph node cells. Draining mediastinal
lymph node cells were stimulated with soluble egg antigen, and superna-
tants were assayed for cytokines by ELISA. (B) Antigen-specific serum IgE
and IgG1 after granuloma formation. Egg antigen–specific antibody iso-
types were assayed by ELISA. Representative data from two repeat experi-
ments using six to eight mice per group. Data are presented as means 6 SD.1569 McKenzie et al.
mice with recombinant IL-4 results in the rapid expulsion
of worms from these animals (data not shown). Thus, once
again there is a dual effect of removing both IL-4 and
IL-13, indicating that these cytokines act in combination to
initiate a potent Th2 response.
IL-4/13–deficient Mice Fail to Express IgE, But Exhibit De-
layed IL-5 Expression and Eosinophilia in Response to N. brasil-
iensis Infection. The normal immune response to N. brasil-
iensis is characterized by Th2 cytokine expression, elevated
levels of IgE expression, and eosinophilia (Fig. 5, A–C). In-
deed, wild-type animals developed a profound eosinophilia
by day 10 p.i. (Fig. 5 B), and total serum IgE had increased
by z100-fold by day 14 p.i. (Fig. 5 C). Unexpectedly, we
found that IL-5 expression and eosinophilia were still in-
duced in the IL-42/2IL-132/2 mice p.i. with N. brasiliensis,
although their production was significantly delayed (Fig. 5,
A and B). However, we failed to detect IgE expression in
the serum of the IL-42/2IL-132/2 mice (Fig. 5 C), and lev-
els of worm antigen–specific IgG1 were also undetectable
(data not shown). Thus, we conclude that although IL-4
and IL-13 are required for the rapid initiation of Th2-like
responses, alternative IL-4/IL-13–independent processes
compensate for their loss and facilitate the expression of
IL-5 and the coordinate development of eosinophilia.
Antigen-specific Antibody Responses Are Biased away from
IgE and IgG1 Production and towards IgG2a and IgG2b in
IL-4/13–deficient Mice. Analysis of total serum Ig isotypes
demonstrated that like the IL-4–deficient animals, mice
lacking both IL-4 and IL-13 had 10–50-fold lower levels of
serum IgG1 and undetectable levels of IgE, whereas other
serum isotypes remained similar to wild-type (data not
shown). However, due to the specific roles of Th2 cell cyto-
kines in regulating humoral immune responses, we have
also analyzed the antigen-specific Ig responses of wild-type,
IL-42/2, IL-132/2, and IL-42/2IL-132/2 mice immunized
with the protein antigen OVA complexed to alum. As
shown in Fig. 6 A, the IL-42/2IL-132/2 animals are se-
verely impaired in their ability to mount an IgG1 response,
a deficiency also apparent in IL-4–deficient animals (Fig. 6 B).
By contrast, IL-132/2 animals develop a normal IgG1 re-
sponse to antigen challenge (Fig. 6 A). Thus, the regulation
of antigen-specific IgG1 responses appears to require IL-4,
but not IL-13. However, cumulative roles for IL-4 and IL-13
in the generation of the antibody responses are suggested
by the highly biased IgG2a and IgG2b responses evoked
upon immunization of the IL-42/2IL-132/2 animals (Fig.
6 A). These isotype profiles are typical of a Th1 response
and are significantly elevated.
Discussion
The generation and analysis of IL-4/13–deficient mice
has enabled us to demonstrate conclusively that these cyto-
kines cooperate in the development of Th2 cell–mediated
immune responses. Due to the close proximity of the IL-4
and IL-13 genes, we used a single vector targeting strategy
to disrupt the expression of both cytokine genes, thereby
allowing us to dissect the potential compensatory roles
played by these cytokines. To define their functional im-
portance, we have used several model antigenic challenges
that are normally characterized by Th2-like responses.
We have found that the Th2-like characteristics of syn-
chronous pulmonary granuloma formation, including eosin-
ophil infiltration and IgE production, are only abolished
Figure 4. Analysis of infection with N. brasiliensis. Determination of
worm burdens. Cohorts of five mice were infected with 400 viable third-
stage N. brasiliensis larvae and killed at the times indicated to obtain intes-
tinal worm counts. Representative data from two repeat experiments.
Data are presented as means 6 SD.
Figure 5. Analysis of cytokines, eosinophilia, and IgE in response to
N. brasiliensis infection. (A) Cytokine expression from Con A–stimulated
mesenteric lymph node cells from wild-type and IL-42/2IL-132/2 animals
after infection with N. brasiliensis. Lymph node cells (2 3 106 cells/ml) were
cultured for 24 h in the presence of Con A (2 mg/ml). Supernatants were
analyzed by cytokine ELISA. Representative data from two repeat experi-
ments are shown. (B) Blood eosinophilia after N. brasiliensis infection. Pe-
ripheral blood was sampled at the times indicated, and the percentage of
eosinophils was determined from blood smears stained with Giemsa. (C)
Total serum IgE expression from wild-type and IL-42/2IL-132/2 animals
pre- and post- (day 14) infection with N . brasiliensis (Nb) assessed by
ELISA. ND, not detected. Representative data from two repeat experi-
ments using five mice per group. Data are presented as means 6 SD.1570 Simultaneous Disruption of IL-4 and IL-13 Genes
when both IL-4 and IL-13 are removed, whereas disrup-
tion of each individual cytokine resulted in only partial ab-
rogation of the response. Thus, our data demonstrate for
the first time that IL-13 also plays a significant role in gran-
uloma formation and, since neither cytokine is fully able to
compensate for the absence of the other, they illustrate a
clear functional specificity for IL-4 and IL-13 in the devel-
opment of the response. Even more significantly, the com-
bined disruption of IL-4 and IL-13 results in the almost
complete abolition of the Th2-driven granuloma response,
demonstrating the additive roles of these two cytokines in
the generation of Th2 responses. In the double-deficient
mice, the virtual absence of eosinophil infiltration, antigen-
specific IgE, and antigen-specific IgG1 is replaced by en-
hanced expression of IFN-g and the upregulation of IgG2a
(data not shown), both indicative of Th1-like responses.
These data generated using the ligand-deficient mice also
clarify any ambiguity raised by the results that have been
generated using signal transducer and activator of transcrip-
tion (Stat)6-deficient and IL-4Ra–deficient mice in which
pulmonary granuloma responses were reported to be more
significantly reduced than in the IL-4–deficient mice (31–34).
While previous studies have demonstrated that IL-13
plays a unique and dominant role in the efficient expulsion
of N. brasiliensis, the double-deficient mice have enabled us
to identify an additive role for IL-4 in this process. These
data are supportive of studies in which the exogenous ad-
ministration of IL-4 induced worm expulsion (35) and our
own experiments showing that exogenous IL-4 can induce
rapid expulsion of N. brasiliensis from the intestines of
IL-13–deficient mice (data not shown). However, since
IL-4–deficient mice expel N. brasiliensis worms normally
(16, 17), the most significant defect in the clearance of
these parasites is the absence of IL-13.
Interestingly, although Th2 responses to N. brasiliensis
infection are significantly delayed in the IL-4/13–deficient
mice, our experiments have also identified alternative, IL-4–
and IL-13–independent mechanisms for IL-5 production
and eosinophilia in IL-4/13–deficient mice. Thus, even in
the absence of IL-4 and IL-13, a response can develop
Th2-like characteristics. The mechanism underlying the
development of IL-5–producing cells is unclear. Such cells
have been recognized in IL-4–deficient mice (2) and IL-4Ra–
deficient mice (3) infected with N. brasiliensis, but normally
only constitute a minor population when evaluated at 7 d
p.i. This is also the case in the IL-4/13–deficient mice,
where IL-5 expression at day 6 p.i. is very low. However,
IL-5 levels in the double-deficient mice become highly el-
evated by day 10 p.i., indicating that, although significantly
delayed, IL-5–producing cells can receive sufficient costim-
ulation to expand in the absence of IL-4 and IL-13 signals.
Since this phenomenon was not observed in the lung re-
sponse to schistosome eggs, it may indicate a unique feature
of the intestinal response to nematode infection.
To date, IgE responses by IL-4/13–deficient mice to a
range of antigenic challenges have remained below the
level of detection in ELISA assays, although IgE responses
were detected in individual cytokine–deficient mice. These
findings support previous studies which have identified
IL-13 and IL-4 as alternative cytokines in the regulation of
IgE expression (1, 2, 7, 36). Furthermore, in the combined
absence of IL-4 and IL-13, the Ig response becomes more
characteristic of a Th1 cell response, illustrating the additive
roles played by these cytokines in the regulation of Ig ex-
pression. This was clearly demonstrated by assessing the an-
tigen-specific Ig isotype response generated against protein
antigen OVA immunization in the presence of the Th2-
inducing adjuvant alum. Although the expression of IgG2a
and IgG2b was only minimally enhanced after the individ-
ual disruption of IL-13, there was a significant increase
when both IL-13 and IL-4 are cotargeted, indicating that at
least in the regulation of Ig expression IL-4 appears able to
compensate more effectively for the loss of IL-13 than
IL-13 does after the disruption of IL-4.
Figure 6. Antigen-specific Ig response to
OVA after immunization. (A) IL-13–defi-
cient (s) and IL-4/13–deficient (n) mice
(shown against preimmune [h] and wild-
type [j] mice); (B) IL-4–deficient (d) mice
(shown against preimmune [h] and
C57BL/6 [r] mice). Cohorts of four ani-
mals were immunized intraperitoneally with
100 mg of OVA adsorbed to alum with sub-
sequent boost injections of OVA/alum after
10 and 20 d. Serum samples were assayed by
ELISA for Ig isotypes. Representative data
from two repeat experiments are shown.1571 McKenzie et al.
The development and analysis of mice with a combined
deficiency for IL-4 and IL-13 expression have clearly dem-
onstrated that IL-4 does not act in isolation in the develop-
ment of Th2 cell responses. It is noteworthy that IL-4 and
IL-13 share the a chain of the IL-4 receptor (37) and con-
sequently signal through related pathways, including Stat6
(38). Our results now explain why IL-4Ra–deficient mice
and Stat6-deficient mice display more severe phenotypic
differences than were reported for the IL-4–deficient mice
(3–5, 17). It is apparent that IL-4 and IL-13 act in conjunc-
tion to ensure the rapid onset of a Th2-like response and
that in their combined absence the vestiges of the Th2
response are abolished or significantly delayed.
Th2 cell–driven responses, particularly IgE and eosino-
philia, are instrumental in disease processes, including aller-
gies, asthma, and helminth infections (29, 30, 39, 40). Indeed,
recent studies have identified that IL-13 is also a major me-
diator in experimental models of allergic asthma (41, 42).
Our findings have obvious implications for the develop-
ment of therapeutic strategies for cytokine/anticytokine
modulation of immune reactions. Thus, to control the ini-
tiation of Th2 cell responses and the abolition of IgE pro-
duction, it appears that it will be necessary to inactivate
both IL-4 and IL-13, and that even then default mecha-
nisms may allow the development of eosinophilia. The IL-4/
13–deficient mice will prove an important tool for dissect-
ing the intimate interaction of these cytokines in numerous
disease states.
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